Abstracts

CHARACTERISTICS AND OUTCOMES CHANGES IN COVID-19 INPATIENTS : A COMPARISON OF 4 WAVES

Four Coronavirus disease 2019 (COVID-19) epidemic waves occurred in France between March 2020 and September 2021. These 4 waves had different intensities and anti severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) therapies including the extensive use of corticosteroids, monoclonal antibodies, high-flow nasal oxygenotherapy, and generalization of vaccination. This single-center retrospective study compared patients’ characteristics and…

LIFE EXPECTANCY AFTER HIV DIAGNOSIS 2008–2018, UNITED STATES

Life expectancy among persons with diagnosed HIV has continued to improve, particularly since introduction of antiretroviral treatment. Building on our previous work we update the life expectancy estimates for an 11-year period from 2008–2018. We used National HIV Surveillance Data on persons ?13 years old at HIV diagnosis, to estimate life expectancy after HIV diagnosis…

ASSOCIATIONS OF MODERN INITIAL ANTIRETROVIRAL DRUG REGIMENS WITH ALL-CAUSE MORTALITY

Regimens including integrase strand inhibitors (INSTIs) are now the most commonly used for persons with HIV (PWH) starting antiretroviral therapy (ART). Trials and observational studies have compared virological failure on INSTI-based with other regimens, but few data are available on mortality among PWH treated with INSTIs in routine care. We compared virological suppression (?50 copies/mL)…

PLASMA RENALASE AND ALL-CAUSE MORTALITY IN PEOPLE WITH AND WITHOUT HIV

Renalase is a recently discovered flavoprotein that can act as a pro-survival signal in cells. Increased levels of renalase in tissue and plasma have been associated with advanced tumor characteristics and increased mortality in patients with pancreatic cancers. Our objective was to examine plasma renalase and determine its association with mortality by HIV status. We…